Okamoto Shigefumi, Yoshii Hironori, Matsuura Masaaki, Kojima Asato, Ishikawa Toyokazu, Akagi Takami, Akashi Mitsuru, Takahashi Michiaki, Yamanishi Koichi, Mori Yasuko
Laboratory of Virology and Vaccinology, Division of Biomedical Research, National Institute of Biomedical Innovation, Ibaraki, Osaka, Japan.
Clin Vaccine Immunol. 2012 Jan;19(1):17-22. doi: 10.1128/CVI.05412-11. Epub 2011 Nov 16.
To maintain immunity against Japanese encephalitis virus (JEV), a formalin-inactivated Japanese encephalitis (JE) vaccine should be administered several times. The repeated vaccination is not helpful in the case of a sudden outbreak of JEV or when urgent travel to a high-JEV-risk region is required; however, there are few single-injection JE vaccine options. In the present study, we investigated the efficacy of a single dose of a new effective JE virus-like particle preparation containing the JE envelope protein (JE-VLP). Although single administration with JE-VLP protected less than 50% of mice against lethal JEV infection, adding poly(γ-glutamic acid) nanoparticles (γ-PGA-NPs) or aluminum adjuvant (alum) to JE-VLP significantly protected more than 90% of the mice. A single injection of JE-VLP with either γ-PGA-NPs or alum induced a significantly greater anti-JEV neutralizing antibody titer than JE-VLP alone. The enhanced titers were maintained for more than 6 months, resulting in long-lasting protection of 90% of the immunized mice. Although the vaccine design needs further modification to reach 100% protection, a single dose of JE-VLP with γ-PGA-NPs may be a useful step in developing a next-generation vaccine to stop a JE outbreak or to immunize travelers or military personnel.
为维持对日本脑炎病毒(JEV)的免疫力,应多次接种福尔马林灭活的日本脑炎(JE)疫苗。在JEV突然爆发或需要紧急前往高JEV风险地区的情况下,重复接种并无帮助;然而,单剂量JE疫苗的选择很少。在本研究中,我们调查了单剂量含JE包膜蛋白的新型有效JE病毒样颗粒制剂(JE-VLP)的效力。尽管单剂量注射JE-VLP只能保护不到50%的小鼠免受致死性JEV感染,但在JE-VLP中添加聚(γ-谷氨酸)纳米颗粒(γ-PGA-NPs)或铝佐剂(明矾)可显著保护超过90%的小鼠。单剂量注射JE-VLP与γ-PGA-NPs或明矾诱导产生的抗JEV中和抗体滴度明显高于单独使用JE-VLP。增强后的滴度可维持6个月以上,从而对90%的免疫小鼠产生持久保护。尽管疫苗设计还需要进一步改进以实现100%的保护,但单剂量含γ-PGA-NPs的JE-VLP可能成为开发下一代疫苗以阻止JE爆发或为旅行者或军事人员进行免疫接种的有益一步。